Biomarker-driven care in asthma: are we there?

  • Aaron Deykin
  • Published 2006 in The Journal of allergy and clinical immunology


Clinical asthma management is limited by the lack of straightforward and clinically applicable techniques to assess control and appropriately adjust therapy. The availability of biomarkers associated with airway caliber, responsiveness, or inflammation has prompted interest in the application of these measures as surrogate asthma end points in clinical… (More)


  • Presentations referencing similar topics